Log in to save to my catalogue

Primary Prevention of ASCVD and T2DM in Patients at Metabolic Risk: An Endocrine Society Clinical Pr...

Primary Prevention of ASCVD and T2DM in Patients at Metabolic Risk: An Endocrine Society Clinical Pr...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2267405407

Primary Prevention of ASCVD and T2DM in Patients at Metabolic Risk: An Endocrine Society Clinical Practice Guideline

About this item

Full title

Primary Prevention of ASCVD and T2DM in Patients at Metabolic Risk: An Endocrine Society Clinical Practice Guideline

Publisher

United States: Copyright Oxford University Press

Journal title

The journal of clinical endocrinology and metabolism, 2019-09, Vol.104 (9), p.3939-3985

Language

English

Formats

Publication information

Publisher

United States: Copyright Oxford University Press

More information

Scope and Contents

Contents

To develop clinical practice guidelines for the primary prevention of atherosclerotic cardiovascular disease (ASCVD) and type 2 diabetes mellitus (T2DM) in individuals at metabolic risk for developing these conditions.
Health care providers should incorporate regular screening and identification of individuals at metabolic risk (at higher risk f...

Alternative Titles

Full title

Primary Prevention of ASCVD and T2DM in Patients at Metabolic Risk: An Endocrine Society Clinical Practice Guideline

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2267405407

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2267405407

Other Identifiers

ISSN

0021-972X,1945-7197

E-ISSN

1945-7197

DOI

10.1210/jc.2019-01338

How to access this item